Company: LIN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060925
Chunk: 55

Company: LINDE PLC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 55
---
 approves annual equity awards with a grant date of on or about March 7th of each year (unless such date falls on a non-business day). The HC Committee may also grant equity awards at other points during the year in connection with new hires or other events, as circumstances require. Linde’s equity grant practices reflect the HC Committee’s intent that grants of equity awards generally be made when the Company is not in possession of material nonpublic information. Linde typically publicly releases fourth quarter and full year financial results in a press release and in an SEC Form 8-K filing in late January or early February of each year, before the February HC Committee meeting at which the equity grants are approved. Linde also files its annual report on Form 10-K by the end of February each year, after the HC Committee meeting at which equity grants are approved, but before the typical March 7th equity grant date. As such, the HC Committee does not time the disclosure of any material nonpublic information for the purpose of affecting the value of equity grants, including those granted in 2024. No stock options were granted to any NEO during 2024 during the period 1) beginning four business days before the filing of Linde’s Form 10-Q, Form 10-K, or Form 8-K that discloses material nonpublic information and 2) ending one business day after the filing of such report. 2024 Equity Award Grants The HC Committee established the target dollar value of 2024 equity awards for each NEO. The HC Committee examined relative responsibility of the NEOs and each NEO’s position to market with consideration of how long they had been in the current role. Particular emphasis was placed on the importance of providing NEOs incentive and appropriate reward for taking high quality actions to support sustainable long-term growth. In order to facilitate the HC Committee’s approval at its February meeting of the total number of shares to be granted and to avoid an outsized impact to grant quantities from short-term fluctuations in the stock price, each award type is valued for compensation purposes based on a 60-day trading average through the middle of February of the grant year. These compensation values are used to derive the number of options and units to be granted to each NEO from the dollar-value LTI targets that are approved by the HC Committee at its January meeting. Because of stock price fluctuations between the compensation valuation period and the grant date in early March when the accounting values are measured, the accounting values of the stock and option awards in

| 54 | Lin